(HealthDay) -- Marqibo (vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with a rare form of blood and bone marrow cancer, Philadelphia chromosome negative ...
Aug 10, 2012
0
0
Taking a 12-week yoga class and practicing at home was linked to less insomnia—but not to fewer or less bothersome hot flashes or night sweats. The link between yoga and better sleep was the only statistically significant ...
Sep 27, 2013
1
0
(HealthDay) -- Marqibo (vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with Philadelphia chromosome negative acute lymphoblastic leukemia (ALL).
Aug 10, 2012
0
0
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
May 22, 2013
0
0
A study of over 20,000 Twitter posts has revealed that less serious side effects of steroids worry patients the most.
Feb 12, 2018
0
6
Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.
May 20, 2013
0
0
Insomnia and sleep apnoea are turning us into major health service consumers, causing us to be less productive at work, and may even lead to serious accidents.
Nov 1, 2012
0
0
Drugmaker Merck & Co. says federal regulators have ruled that they won't approve high doses of its experimental insomnia medication because of concerns about their safety.
Jul 1, 2013
0
0
A new study suggests that frequent binge drinking is associated with insomnia symptoms in older adults.
Jun 10, 2013
0
0
(AP)—Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its experimental insomnia medication, suvorexant (SOO'vor-eks-ant).
Nov 8, 2012
0
0
